Histopathologic Characteristics of Invasive and Non-invasive Ductal Tumors have Relationship with Different Phenotypes of ER / PR Receptors in Breast Cancer Patients

Authors

  • Rahim Golmohammadi Associate Professor, Department of Anatomy, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran Author
  • Mohammad Reza Mohajeri Assistant Professor, Department of Pathology, Shahid Sadoughi Hospital, Isfahan, Iran Author
  • Alireza Mosavi Jarrahi Associate Professor of Epidemiology, Faculty of Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran Author
  • Ali Reza Moslem Assistant Professor, Department of Biochemistry, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran Author
  • Akbar Pejhan Professor, Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran Author
  • Ali gohari Department of Biochemistry, School of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran Author

DOI:

https://doi.org/10.31557/apjcb.2021.6.3.181-185

Keywords:

Breast Neoplasm, ER / PR receptor expression, Grade, Stage, Tumor type

Abstract

Objective: Contradictory reports have been published regarding the expression levels of the hormone receptors of estrogen and progesterone (ER / PR) and theirclinical importance in diagnosis of breast cancer. The aim of this study was to evaluate the relationship between pathological features of invasive and non-invasive ductal tumors by different ER / PR phenotypes.
Methods: This descriptive-analytical study was performed on 74 specimens of breast cancer referred to Isfahan Hospitals for diagnosis between 2015 - 2018. After fixation of the specimens in formalin, tissue passage, cross section and H / E staining, the specimens were divided into two groups: non- invasive and Invasive ductal Carcinoma. After removing of mask, expression of different ER / PR phenotypes was performed using primary monoclonal antibody and immunohistochemically methods.
Results: From 74 malignant specimens, 61 (82.4%) were in the category of invasive ductal tumors and 13 cases (17.6%) were in the category of non-invasive ductal tumors. Out of 73 patients with positive ER or PR phenotype 47 samples (63.5%) had ER + / PR +phenotypes, 6 samples had (8.1%) ER+ / PR –phenotype, 20 samples (27%) had ER- / PR + phenotype and only one sample (1.4%) had the ER- / PR- phenotype and was in the category of invasive ductal tumors. There was not detected ER- / PR- phenotype expression in non-invasive ductal tumor. Further analysis showed that there were not significant difference between ER / PR phenotype and tumor stage (p =0.36) or with tumor Grade (P=0.38), high age of menopause or post menopause (P> 0.05).
Conclusion: Our data shows that expression of ER- / PR- phenotype only was detected in invasive ductal tumor. It is thought that the tumor type maybe affects the expression of different types of ER / PR hormone receptor phenotypes in breast cancer patients.

Author Biographies

  • Rahim Golmohammadi, Associate Professor, Department of Anatomy, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran

    Associate Professor, Department of Anatomy, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran

  • Mohammad Reza Mohajeri, Assistant Professor, Department of Pathology, Shahid Sadoughi Hospital, Isfahan, Iran

    Assistant Professor, Department of Pathology, Shahid Sadoughi Hospital, Isfahan, Iran

  • Alireza Mosavi Jarrahi, Associate Professor of Epidemiology, Faculty of Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Associate Professor of Epidemiology, Faculty of Medical School, Shahid Beheshti University of Medical

                    Sciences, Tehran, Iran

  • Ali Reza Moslem, Assistant Professor, Department of Biochemistry, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran

    Assistant Professor, Department of Biochemistry, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran

  • Akbar Pejhan, Professor, Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran

    Professor, Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran

Published

2021-07-09

Issue

Section

Research Articles/ Original Work